Complete Response Letter

Red light traffic
Pharma

Xspray's Dasynoc knocked back by FDA over production once again

Less than a year after the FDA turned down the filing for its leukemia prospect Dasynoc, Xspray Pharma has again hit a wall at the U.S. regulator.
Fraiser Kansteiner Aug 20, 2026 2:50pm
Graphic image of a red thumbs down against a blue background

ITM cancer drug spurned by FDA over manufacturing qualms

Aug 10, 2026 11:25am
scissor cutting rope

Novo’s Catalent plant ditched in FDA refiling of SMA drug

Aug 10, 2026 10:06am
FDA

2 FDA citations trouble Hengrui, Elevar’s liver cancer combo

Jul 28, 2026 3:02pm
Traffic light go start restart green light

After 3 CRLs, FDA approves Outlook's AMD drug Lytenava

Jul 27, 2026 11:51am
FDA stop sign

FDA rejects Hengrui, Elevar PD-1 liver cancer combo a 3rd time

Jul 10, 2026 10:55am